Piretanide

Chemical formula: C₁₇H₁₈N₂O₅S  Molecular mass: 362.4 g/mol  PubChem compound: 4849

Therapeutic indications

Piretanide is indicated for:

Indication

Population group: only adults (18 - 65 years old)

at least one of
Ascites
Hypertension
Nephrotic syndrome
Pulmonary oedema
Renal failure
Oedema, not elsewhere classified and additionally Congestive heart failure

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Piretanide is contraindicated in the following cases:

Contraindication

at least one of
Hypokalaemia
Anuria and oliguria
Hepatitis A with hepatic coma
Acute hepatitis B with delta-agent (coinfection) with hepatic coma
Acute hepatitis B without delta-agent with hepatic coma
Unspecified viral hepatitis with hepatic coma
Pregnancy
Lactation
Volume depletion

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: ARELIX Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈